Collaboration to improve cancer care and reduce disparities
Official title: Administrative Core
Funded at University of California Riverside · NIH-10933465 · Data updated 2026-11-12
This study is all about bringing together the University of California, Riverside and the City of Hope Comprehensive Cancer Center to make cancer care better for patients, helping them access new treatments and receive more personalized care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Riverside NIH-funded |
| Lab location | 1 site (Riverside, United States) |
| Project start | September 22, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $223,543 |
| NIH project number | 5U54CA285114-02 |
| Project ID | NIH-10933465 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals affected by cancer, particularly those from underserved communities.
✕Less likely to help
Patients who are not affected by cancer or who do not belong to the targeted communities may not receive direct benefits from this research.
What this research studies
This research focuses on enhancing the partnership between the University of California, Riverside and the City of Hope Comprehensive Cancer Center to improve cancer care. It aims to provide strong scientific leadership and administrative support to ensure effective planning and implementation of cancer-related initiatives. The project involves collaboration with various advisory boards to guide efforts in eliminating health disparities in cancer treatment. Patients may benefit from improved access to innovative therapies and better-informed care strategies.
Why it matters
Potential benefit: If successful, this research could lead to more equitable cancer treatment options and improved patient outcomes.
How similar studies have gone: Previous collaborations in cancer research have shown success in addressing disparities and improving treatment outcomes, indicating a promising approach.
Where this research is happening
-
University of California Riverside
Riverside, United States Active
Researchers
- Principal investigator: Martinez, Ernest — University of California Riverside
- Study coordinator: Martinez, Ernest
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.